Amneal Pharmaceuticals, Inc. (AMRX)
20.02
+0.12
(+0.58%)
USD |
NASDAQ |
Oct 12, 16:00
20.20
+0.18
(+0.87%)
After-Hours: 20:00
Amneal Pharmaceuticals Net Income (TTM) : 215.32M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 215.32M |
| March 31, 2026 | 181.32M |
| December 31, 2025 | 127.93M |
| September 30, 2025 | 57.62M |
| June 30, 2025 | 51.24M |
| March 31, 2025 | 32.42M |
| December 31, 2024 | -73.88M |
| September 30, 2024 | -146.48M |
| June 30, 2024 | -133.20M |
| March 31, 2024 | -120.31M |
| December 31, 2023 | -48.72M |
| September 30, 2023 | 38.76M |
| June 30, 2023 | 11.34M |
| March 31, 2023 | -258.42M |
| December 31, 2022 | -254.79M |
| September 30, 2022 | -269.39M |
| June 30, 2022 | -273.09M |
| March 31, 2022 | -0.835M |
| December 31, 2021 | 20.17M |
| September 30, 2021 | 33.67M |
| June 30, 2021 | 17.73M |
| March 31, 2021 | -38.39M |
| December 31, 2020 | 68.58M |
| September 30, 2020 | 10.64M |
| June 30, 2020 | -330.72M |
| Date | Value |
|---|---|
| March 31, 2020 | -357.30M |
| December 31, 2019 | -603.57M |
| September 30, 2019 | -559.00M |
| June 30, 2019 | -178.14M |
| March 31, 2019 | -177.37M |
| December 31, 2018 | -52.50M |
| September 30, 2018 | -31.54M |
| June 30, 2018 | -48.66M |
| March 31, 2018 | 1.386M |
| December 31, 2017 | 1.269M |
| September 30, 2017 | -278.94M |
| June 30, 2017 | -458.62M |
| March 31, 2017 | -461.62M |
| December 31, 2016 | -472.03M |
| September 30, 2016 | -181.02M |
| June 30, 2016 | 34.07M |
| March 31, 2016 | 34.92M |
| December 31, 2015 | 39.00M |
| September 30, 2015 | 27.69M |
| June 30, 2015 | 7.672M |
| March 31, 2015 | 44.60M |
| December 31, 2014 | 57.35M |
| September 30, 2014 | 47.61M |
| June 30, 2014 | 31.69M |
| March 31, 2014 | 2.242M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Liquidia Corp. | 138.61M |
| Eli Lilly & Co. | 26.71B |
| Johnson & Johnson | 21.04B |
| Merck & Co., Inc. | 3.169B |
| Viatris, Inc. | -410.70M |